MCDA framework for Ophan Drugs in Spain Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain Avaliable at: https://www.tandfonline.com/doi/abs/10.1080/21678707.2019.1652163?journalCode=ieod20 Omakase2020-09-23T17:57:09+00:00August 8th, 2019|Articles| Share This Article LinkedInEmail Related Posts Studio the economically justifiable price in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy Studio the economically justifiable price in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy September 13th, 2022 Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System June 22nd, 2022 The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis June 22nd, 2022 New publication about the incidence and management of patients with methotrexate delayed elimination New publication about the incidence and management of patients with methotrexate delayed elimination February 15th, 2022 New publication about the socio-economic burden on patients, and their caregivers, suffering from severe thrombocytopenia associated with chronic liver disease (CLD) who undergo invasive procedures in Spain New publication about the socio-economic burden on patients, and their caregivers, suffering from severe thrombocytopenia associated with chronic liver disease (CLD) who undergo invasive procedures in Spain January 11th, 2022 New publication in EC Gastroenterology and Digestive System New publication in EC Gastroenterology and Digestive System December 9th, 2021 New publication about the treatment of focal-onset seizures (FOS) in patients with drug resistant epilepsy (DRE) in Spain New publication about the treatment of focal-onset seizures (FOS) in patients with drug resistant epilepsy (DRE) in Spain October 6th, 2021 New publication about the treatment of triple-class refractory multiple myeloma in Spain New publication about the treatment of triple-class refractory multiple myeloma in Spain July 15th, 2021
